Compare ABUS & ODC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABUS | ODC |
|---|---|---|
| Founded | 2005 | 1941 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Miscellaneous manufacturing industries |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 848.1M | 790.1M |
| IPO Year | N/A | N/A |
| Metric | ABUS | ODC |
|---|---|---|
| Price | $4.52 | $52.84 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $5.00 | N/A |
| AVG Volume (30 Days) | ★ 1.1M | 57.8K |
| Earning Date | 11-13-2025 | 12-08-2025 |
| Dividend Yield | N/A | ★ 1.36% |
| EPS Growth | N/A | ★ 36.27 |
| EPS | N/A | ★ 3.70 |
| Revenue | $14,606,000.00 | ★ $485,572,000.00 |
| Revenue This Year | $125.30 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $14.28 |
| Revenue Growth | ★ 116.64 | 10.97 |
| 52 Week Low | $2.71 | $33.55 |
| 52 Week High | $5.10 | $69.76 |
| Indicator | ABUS | ODC |
|---|---|---|
| Relative Strength Index (RSI) | 54.15 | 38.33 |
| Support Level | $4.09 | $52.76 |
| Resistance Level | $4.47 | $55.88 |
| Average True Range (ATR) | 0.19 | 1.59 |
| MACD | 0.01 | 0.00 |
| Stochastic Oscillator | 93.64 | 22.58 |
Arbutus Biopharma Corp is a clinical-stage biopharmaceutical company focused on infectious diseases. The company is leveraging its extensive virology expertise to identify and develop novel therapeutics with distinct mechanisms of action, which can be combined to provide a functional cure for patients with chronic hepatitis B virus (cHBV). Its pipeline of internally developed, proprietary compounds includes an RNAi therapeutic, imdusiran (AB-729), and an oral PD-L1 inhibitor, AB-101. In addition, the company is also focused on maximizing the opportunity for its in-house developed Lipid Nanoparticle (LNP) delivery technology.
Oil-Dri Corp of America develops, manufactures, and markets sorbent products made predominantly from clay. Its absorbent offerings, which draw liquid up, include cat litter, floor products, toxin control substances for livestock, and agricultural chemical carriers. The company has two segments based on the different characteristics of two primary customer groups, namely the Retail and Wholesale Products Group, which derives maximum revenue, and the Business-to-Business Products Group. The company's products are sold under various brands such as Cat's Pride, Jonny Cat, Amlan, Agsorb, Verge, Pure-Flo, and Ultra-Clear.